Alexandria Real Estate Equities, Inc. Stock 12‑Month Price Target Raised to $52.36, Implies 8% Upside
Analyst estimates for Alexandria Real Estate Equities, Inc. (ARE) show its average 12-month price target increased from $51.79 to $52.36. Forecasts range from $46 to $60. Based on the Aug. 6 close, the target implies about 8% upside. The consensus rating remains “Hold” with 2 Buys, 12 Holds, and 3 Sells.
How this was made
The 30-second read
Why it matters
For traders, the actionable signal is sentiment drift from a higher consensus target, but the unchanged Hold consensus and lack of new operating or guidance data reduce the immediacy of the catalyst.
Market read
This is primarily a consensus-target update, not a fundamental disclosure, so it is more useful for positioning than for revaluing the business.
What to watch
The article does not specify which analysts changed views, the rationale for the target increase, or whether any Sell-to-Hold/Buy-to-Hold shifts occurred, limiting conviction.
Background
The piece summarizes FactSet-sourced analyst estimates: average 12-month price target and the distribution of Buy/Hold/Sell ratings.
Ticker impact
Analyst consensus price target for Alexandria Real Estate Equities rose from $51.79 to $52.36, implying about 8% upside from the Aug. 6 close.
Near-term bias modestly higher, with limited follow-through unless accompanied by new earnings, guidance, or rating changes.
The only disclosed change is the average analyst target and unchanged Hold consensus; without new company-specific catalysts, impact is likely sentiment-driven and incremental.
Market effects
Limited read-through to REIT peers since this is a single-name analyst target update with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
A higher average target can still coexist with a Hold consensus, suggesting the market may already price the improvement and that upside may be capped by valuation or fundamentals not discussed here.
Key entities
- companyAlexandria Real Estate Equities, Inc.
Subject of the article; consensus 12-month price target raised to $52.36 with Hold rating still dominant.
